Zobrazeno 1 - 10
of 12
pro vyhledávání: ''
Autor:
Joosep Paats, Liisi Leis, Merike Luman, Kai Lauri, Ivo Fridolin, Annika Adoberg, Jürgen Arund, Risto Tanner
Publikováno v:
Toxins
Volume 13
Issue 4
Toxins, Vol 13, Iss 255, p 255 (2021)
Volume 13
Issue 4
Toxins, Vol 13, Iss 255, p 255 (2021)
Optical monitoring of spent dialysate has been used to estimate the removal of water-soluble low molecular weight as well as protein-bound uremic toxins from the blood of end stage kidney disease (ESKD) patients. The aim of this work was to develop a
Publikováno v:
Toxins
Toxins, Vol 13, Iss 159, p 159 (2021)
Toxins, Vol 13, Iss 159, p 159 (2021)
Unilateral peripheral facial nerve palsy jeopardizes quality of life, rendering psychological consequences such as low self-esteem, social isolation, anxiety, and depression. Among therapeutical approaches, use of Botulinum toxin type A (BoNT-A) on t
Autor:
Fitsum Guebre-Egziabher, Christophe O. Soulage, Caroline C. Pelletier, Nans Florens, Laurent Juillard, Sandrine Lemoine, Laurence Dubourg
Publikováno v:
Toxins
Toxins, Vol 12, Iss 567, p 567 (2020)
Toxins, MDPI, 2020, 12 (9), pp.567. ⟨10.3390/toxins12090567⟩
Volume 12
Issue 9
Toxins, Vol 12, Iss 567, p 567 (2020)
Toxins, MDPI, 2020, 12 (9), pp.567. ⟨10.3390/toxins12090567⟩
Volume 12
Issue 9
Lipid aldehydes originating from the peroxidation of n-3 and n-6 polyunsaturated fatty acids are increased in hemodialysis (HD) patients, a process already known to promote oxidative stress. However, data are lacking for patients with chronic kidney
Autor:
Christopher C Gallen, Mehran Kavoosi, Mojgan Kavoosi, Terry E. O'Reilly, Peng Chai, Walter Korz, Caroline Engel, Robert M Lester
Publikováno v:
Toxins
Volume 12
Issue 8
Toxins, Vol 12, Iss 511, p 511 (2020)
Volume 12
Issue 8
Toxins, Vol 12, Iss 511, p 511 (2020)
Tetrodotoxin (TTX) is a highly specific voltage-gated sodium channel (VGSC) blocker in clinical evaluation as a peripheral-acting analgesic for chronic pain. This study presents the first published results of the safety including cardiac liability of
Publikováno v:
Toxins
Volume 12
Issue 3
Toxins, Vol 12, Iss 3, p 168 (2020)
Volume 12
Issue 3
Toxins, Vol 12, Iss 3, p 168 (2020)
The purpose of this study is to evaluate the effects of botulinum toxin type A (BoNT-A) for managing sleep bruxism (SB) in a randomized, placebo-controlled trial. Thirty SB subjects were randomly assigned into two groups evenly. The placebo group rec
Autor:
Ciro De Luca, Martina Cafalli, Filippo Baldacci, Gabriele Siciliano, Elisa Dini, Ubaldo Bonuccelli, Annalisa Lo Gerfo, Lucia Chico, Sonia Mazzucchi, Sara Gori
Publikováno v:
Toxins
Toxins, Vol 11, Iss 10, p 608 (2019)
Volume 11
Issue 10
Toxins, Vol 11, Iss 10, p 608 (2019)
Volume 11
Issue 10
The pathophysiological mechanisms of migraine transformation are debated. Modifications of plasma oxidative stress biomarkers have been described in chronic migraine. OnabotulintoxinA (BoNT/A) treatment, approved for chronic migraine prophylaxis, pos
Autor:
Marcin Ufnal, Anna Bielak-Zmijewska, Krzysztof J. Filipiak, Grazyna Mosieniak, Agnieszka Kapłon-Cieślicka, Ewa Sikora, Robert Hołyst, Aleksandra Gasecka, Kinga Jaworska, Michał Konwerski, Marta Pilz, Dagmara Hering
Publikováno v:
Toxins
Toxins, Vol 11, Iss 9, p 490 (2019)
Volume 11
Issue 9
Toxins, Vol 11, Iss 9, p 490 (2019)
Volume 11
Issue 9
Trimethylamine-N-oxide (TMAO) has been suggested as a marker and mediator of cardiovascular diseases. However, data are contradictory, and the mechanisms are obscure. Strikingly, the role of the TMAO precursor trimethylamine (TMA) has not drawn atten
Autor:
Kazuya Yoshida
Publikováno v:
Toxins
Volume 11
Issue 1
Toxins, Vol 11, Iss 1, p 51 (2019)
Volume 11
Issue 1
Toxins, Vol 11, Iss 1, p 51 (2019)
Lingual dystonia is a debilitating type of oromandibular dystonia characterized by involuntary, often task-specific, contractions of the tongue muscle activated by speaking or eating. Botulinum neurotoxin (BoNT) has been used to treat lingual dystoni
Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients
Publikováno v:
Toxins
Toxins, Vol 10, Iss 10, p 403 (2018)
Volume 10
Issue 10
Toxins, vol. 10, no. 10, 403, 2018.
Toxins, Vol 10, Iss 10, p 403 (2018)
Volume 10
Issue 10
Toxins, vol. 10, no. 10, 403, 2018.
Association of higher serum levels of uremic toxins and inflammatory markers with poorer physical performance is understudied. We measured the six-minute walk test (6MWT), 10 repetition sit-to-stand test (STS-10), handgrip strength (HGS), and Human A
Autor:
Araldo Causero, Christian Lettieri, Paolo Bortolotti, Roberto Eleopra, Andrea Santamato, Carmelo Lentino, Grazia Devigili, Sara Rinaldo, Carmine Tamborino
Publikováno v:
Toxins
Toxins, Vol 10, Iss 11, p 448 (2018)
Volume 10
Issue 11
Toxins, Vol 10, Iss 11, p 448 (2018)
Volume 10
Issue 11
Background: Hip Osteoarthritis (OA) causes pain and disability. Here we evaluate abobotulinumtoxinA (Dysport®
) (AboBoNT-A) injections versus placebo as a novel treatment option to improve hip range of motion, pain and quality of life. Method
) (AboBoNT-A) injections versus placebo as a novel treatment option to improve hip range of motion, pain and quality of life. Method